UBS Reiterates Neutral Rating on Myriad Genetics (MYGN)

Go back to UBS Reiterates Neutral Rating on Myriad Genetics (MYGN)
Myriad Genetics, Inc. (NASDAQ: MYGN) Delayed: 3.14 -0.04 (1.26%)
Previous Close $3.18    52 Week High $45.34 
Open $3.11    52 Week Low $15.92 
Day High $3.16    P/E 1.35 
Day Low $3.09    EPS $2.33 
Volume 272,842